182 related articles for article (PubMed ID: 31948534)
41. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
Liu X; Qi D; Qi J; Mao Z; Li X; Zhang J; Li J; Gao W
Oncol Rep; 2016 Jan; 35(1):155-62. PubMed ID: 26530274
[TBL] [Abstract][Full Text] [Related]
42. Analysis of Long Non-Coding RNA Expression Profiles in Non-Small Cell Lung Cancer.
Wang L; Chen Z; An L; Wang Y; Zhang Z; Guo Y; Liu C
Cell Physiol Biochem; 2016; 38(6):2389-400. PubMed ID: 27299310
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.
Shang Y; Zang A; Li J; Jia Y; Li X; Zhang L; Huo R; Yang J; Feng J; Ge K; Yang Y; Zhang Y; Jiang J
Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765
[TBL] [Abstract][Full Text] [Related]
44. Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer.
Zhu B; Yan Y; Shao B; Tian L; Zhou W
J Int Med Res; 2018 Apr; 46(4):1517-1527. PubMed ID: 29363378
[TBL] [Abstract][Full Text] [Related]
45. Testicular orphan receptor 4 (TR4) is a marker for metastasis and poor prognosis in non-small cell lung cancer that drives the EMT phenotype.
Zhang L; Zhang J; Ma Y; Chen J; Dong B; Zhao W; Wang X; Zheng Q; Fang F; Yang Y
Lung Cancer; 2015 Sep; 89(3):320-8. PubMed ID: 26144287
[TBL] [Abstract][Full Text] [Related]
46. TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression.
Wang Y; Zhou Z; Wang X; Zhang X; Chen Y; Bai J; Di W
Int J Biol Sci; 2018; 14(14):2073-2082. PubMed ID: 30585270
[TBL] [Abstract][Full Text] [Related]
47. MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer.
Wang Z; Li Z; Wu C; Wang Y; Xia Y; Chen L; Zhu Q; Chen Y
Med Oncol; 2014 Jan; 31(1):790. PubMed ID: 24310811
[TBL] [Abstract][Full Text] [Related]
48. TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins.
Zhan W; Han T; Zhang C; Xie C; Gan M; Deng K; Fu M; Wang JB
PLoS One; 2015; 10(11):e0142596. PubMed ID: 26599082
[TBL] [Abstract][Full Text] [Related]
49. BPTF biomarker correlates with poor survival in human NSCLC.
Gong YC; Liu DC; Li XP; Dai SP
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):102-107. PubMed ID: 28121349
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.
Wang Y; Dong QZ; Fu L; Stoecker M; Wang E; Wang EH
Mol Carcinog; 2013 Nov; 52(11):890-9. PubMed ID: 22753141
[TBL] [Abstract][Full Text] [Related]
51. Expression of THOP1 and its relationship to prognosis in non-small cell lung cancer.
Qi L; Li SH; Si LB; Lu M; Tian H
PLoS One; 2014; 9(9):e106665. PubMed ID: 25180910
[TBL] [Abstract][Full Text] [Related]
52. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
[TBL] [Abstract][Full Text] [Related]
53. TRIM59 overexpression correlates with poor prognosis and contributes to breast cancer progression through AKT signaling pathway.
Liu Y; Dong Y; Zhao L; Su L; Diao K; Mi X
Mol Carcinog; 2018 Dec; 57(12):1792-1802. PubMed ID: 30175868
[TBL] [Abstract][Full Text] [Related]
54. [Relationship among the expression of lymphatic vessel density, microvessel density, carcinoembryonic antigenic mRNA, KAI1, and Kiss-1, and prognosis in patients with non-small cell lung cancer].
Wang G; Wang Z; Li C; Wang P; Chai D; Cheng Z
Zhongguo Fei Ai Za Zhi; 2012 Jun; 15(6):348-54. PubMed ID: 22681921
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer.
Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D
Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417
[TBL] [Abstract][Full Text] [Related]
56. Prognostic significance of TRIM59 for cancer patient survival: A systematic review and meta-analysis.
Wang M; Chao C; Luo G; Wang B; Zhan X; Di D; Qian Y; Zhang X
Medicine (Baltimore); 2019 Nov; 98(48):e18024. PubMed ID: 31770215
[TBL] [Abstract][Full Text] [Related]
57. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
[TBL] [Abstract][Full Text] [Related]
58. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
Yang J; Liu H; Wang H; Sun Y
Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
[TBL] [Abstract][Full Text] [Related]
59. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
Feng A; Tu Z; Yin B
Oncotarget; 2016 Apr; 7(15):20507-19. PubMed ID: 26840258
[TBL] [Abstract][Full Text] [Related]
60. Over-expression of CircRNA_100876 in non-small cell lung cancer and its prognostic value.
Yao JT; Zhao SH; Liu QP; Lv MQ; Zhou DX; Liao ZJ; Nan KJ
Pathol Res Pract; 2017 May; 213(5):453-456. PubMed ID: 28343871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]